Corient Private Wealth’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$212K Sell
9,832
-13,277
-57% -$257K ﹤0.01% 2528
2025
Q4
$497K Buy
23,109
+10,812
+88% +$228K ﹤0.01% 2318
2025
Q3
$237K Sell
12,297
-143
-1% -$2.55K ﹤0.01% 2270
2025
Q2
$213K Buy
12,440
+5,281
+74% +$225K ﹤0.01% 2206
2025
Q1
$457K Buy
7,159
+691
+11% +$72.7K ﹤0.01% 1640
2024
Q4
$786K Buy
+6,468
New +$793K ﹤0.01% 1420
2024
Q3
Sell
-7,828
Closed -$1.24M 2560
2024
Q2
$1.24M Buy
7,828
+1,347
+21% +$173K ﹤0.01% 1246
2024
Q1
$839K Buy
6,481
+492
+8% +$60.3K ﹤0.01% 1373
2023
Q4
$578K Buy
5,989
+1,941
+48% +$186K ﹤0.01% 1538
2023
Q3
$491K Buy
+4,048
New +$458K ﹤0.01% 1511
2023
Q1
Sell
-3,934
Closed -$510K 2051
2022
Q4
$510K Buy
+3,934
New +$456K ﹤0.01% 1139

Other funds holding SRPT